Case of using mycophenolate in combination with steroids for concurrent macrophage activation syndrome and lupus flare.


Journal

BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291

Informations de publication

Date de publication:
07 Apr 2020
Historique:
entrez: 10 4 2020
pubmed: 10 4 2020
medline: 1 1 2021
Statut: epublish

Résumé

This report highlights the importance of tailored treatment strategies in severe systemic lupus erythematosus (SLE) flares driving the life-threatening condition, macrophage activation syndrome (MAS). We report the case of a 42-year-old woman with active systemic lupus erythematosus (SLE) who was diagnosed with MAS within 3 days of onset of lethargy, rash, joint pain and significant cytopenias. This early diagnosis meant that her condition was managed with less intensive immunosuppression with only modest doses of steroids and mycophenolate mofetil.

Identifiants

pubmed: 32269047
pii: 13/4/e231554
doi: 10.1136/bcr-2019-231554
pmc: PMC7167458
pii:
doi:

Substances chimiques

Enzyme Inhibitors 0
Glucocorticoids 0
Prednisolone 9PHQ9Y1OLM
Mycophenolic Acid HU9DX48N0T

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Front Immunol. 2014 Oct 07;5:491
pubmed: 25339958
Case Rep Med. 2018 Sep 26;2018:5979386
pubmed: 30356389
Rheumatol Adv Pract. 2019 May 14;3(1):rkz013
pubmed: 31432001
Case Rep Rheumatol. 2017;2017:4159727
pubmed: 29062579
Clin Rheumatol. 2018 Dec;37(12):3329-3335
pubmed: 29663156
J Rheumatol. 2007 May;34(5):1133-8
pubmed: 17343315
J Rheumatol. 2006 Feb;33(2):438-40
pubmed: 16482659
Rheumatology (Oxford). 2019 Nov 1;58(Suppl 6):vi23-vi30
pubmed: 31769857
Am J Case Rep. 2018 Jun 22;19:734-738
pubmed: 29930239
Arthritis Rheumatol. 2014 Aug;66(8):2297-307
pubmed: 24756912
Open Access Rheumatol. 2018 Aug 31;10:117-128
pubmed: 30214327

Auteurs

Kavina Shah (K)

Rheumatology Department, West Middlesex University Hospital NHS Trust, London, UK kavina.shah@ucl.ac.uk.

Andrew Porter (A)

Rheumatology Department, West Middlesex University Hospital NHS Trust, London, UK.

Gagandeep Takhar (G)

Rheumatology Department, West Middlesex University Hospital NHS Trust, London, UK.

Venkat Reddy (V)

Centre for Rheumatology, University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH